Alacrita Set to Change the Face of Life Science ConsultingBy Alacrita, PRNE
Sunday, November 14, 2010
LONDON, November 15, 2010 - Alacrita, a newly created life science consultancy, is set to
change the face of consulting in the sector. Alacrita has been formed by a
broad team of consultants with real-world management experience of delivering
success at all key points in the development of pharma and biotech companies
and products. The team at Alacrita is focused on providing value added
business solutions to a much broader range of companies across the sector in
a timely and cost-effective manner.
Alacrita is led by its two founding partners, Dr Anthony
Walker and Rob Johnson. Dr Walker has a background as biotech CEO and as a
management consultant to the pharma industry. He has previously worked for
Onyvax, Arthur D Little and the Wilkerson Group. Rob Johnson has many years
of biotech business development expertise gained while working at Onyvax. The
founding partners at Alacrita are supported by more than 40 consultants with
significant strategic, corporate, product development and regulatory
experience in the life science sector.
Anthony Walker, Partner at Alacrita, said, "The creation of
Alacrita has been designed to fill a real need in the life science consulting
sector. By providing access to consultants with a broad range of real-world
managerial experience we have already demonstrated that we are able to
deliver real value to our clients in a highly efficient and cost-effective
manner. At Alacrita we believe there is no substitute to having been involved
in the direct management of critical, corporate changing activities."
Alacrita is focused on delivering tailor-made solutions that
add value to the clients they consult to. Alacrita starts each assignment by
applying its real-world expertise and experience to rapidly assess and
understand the challenges faced by its clients. It is the ability to identify
these key issues and to develop solutions that exactly meet their client's
needs in a rapid and cost-effective manner that sets Alacrita apart from its
Dr John Brown, Chairman of BTG plc and a member of the
Alacrita Advisory Group, said, "The launch of Alacrita could not have come at
a better time. With life science companies of all sizes facing a rapidly
changing and challenging environment, the need to access a consultancy with
significant real-world experience has never been greater. I have little doubt
that the Alacrita team will quickly establish itself as the consultancy of
choice for companies from the pharma, biotech and medtech industries seeking
solutions that will greatly enhance their chances of success."
Alacrita's ability to create value for its clients is based on
providing access to the right team of consultants who combine extensive
international industry experience (strategic, technical and commercial),
broad functional capabilities and a track record of success across the life
science sector. In addition, Alacrita's consultants are able to become
involved directly in the execution of key projects, allowing clients to meet
their resourcing needs at critical times in their corporate development.
Rob Johnson, Partner at Alacrita, said, "The initial response
we have had to the creation of Alacrita has reinforced our view that we can
make a real difference to the face of life science consulting. With a roster
of over 40 experienced consultants and the ability to create tailored teams
that can address all critical business areas, we are confident that we can
quickly become the first choice consultancy for companies across the life
About Alacrita Consulting
Alacrita is rapidly growing consultancy that provides
tailored, value added solutions to clients in the pharmaceutical,
biotechnology and life science sectors.
Alacrita applies its real-world expertise and experience to
rapidly assess and understand the challenges faced by its clients and to
develop solutions that exactly meet their needs. This blueprint is then used
to access the Alacrita consultants best suited to deliver projects on time
and on budget.
Alacrita provides its clients with access to consultants who
combine extensive international industry experience (strategic, technical and
commercial), broad functional capabilities and a track record of success
across the life science sector.
In addition, Alacrita's network of over 40 consultants with
"hands on" allows management experience allows it to solve client resourcing
needs at critical times in their corporate development.
Since inception, Alacrita and its network have completed
successful consulting projects for big pharma, biotech companies, life
science investors, government bodies and charities.
For further information, please contact: Anthony Walker or Rob Johnson firstname.lastname@example.org or email@example.com +44(0)207-691-4915
For further information, please contact: Anthony Walker or Rob Johnson, awalker at alcritaconsulting.com or rjohnson at alacritaconsulting.com, +44(0)207-691-4915
Tags: Alacrita, London, November 15, United Kingdom